))
Episode 14. MRD in Multiple Myeloma
Manage episode 353523172 series 3369804
Content provided by Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
1. Excellent paper on harmonization of performing and reporting MRD in multiple myeloma:
https://www.nature.com/articles/s41375-020-01012-4
2. Does CR really matter in the era of MRD? Landmark paper from the Spanish Group:
https://pubmed.ncbi.nlm.nih.gov/35560160/
3. Meta-analysis showing individual-level prognostic impact of MRD on long-term outcomes in multiple myeloma:
https://pubmed.ncbi.nlm.nih.gov/33284948/
4. MASTER Trial-The first trial testing MRD-adapted treatment strategy in multiple myeloma :
https://pubmed.ncbi.nlm.nih.gov/34898239/
48 episodes
Share
